-
1 Comment
Gene Techno Science Co.,Ltd is currently in a long term uptrend where the price is trading 7.6% above its 200 day moving average.
From a valuation standpoint, the stock is 80.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 13.8.
Gene Techno Science Co.,Ltd's total revenue rose by 30.3% to $546M since the same quarter in the previous year.
Its net income has increased by 107.4% to $25M since the same quarter in the previous year.
Based on the above factors, Gene Techno Science Co.,Ltd gets an overall score of 4/5.
| Sector | Healthcare |
|---|---|
| Industry | Biotechnology |
| Exchange | TSE |
| CurrencyCode | JPY |
| ISIN | JP3386460004 |
| Beta | 1.0 |
|---|---|
| Market Cap | 12B |
| PE Ratio | None |
| Target Price | 450 |
| Dividend Yield | None |
Kidswell Bio Corporation develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan. Its pipeline products include GBS-001 and GBS-010 for oncology; GBS-007 for ophthalmic disease; and GBS-011 for renal disease. The company pipeline products also include GCT-103 that is indicated for pediatric cerebral palsy; GCT-102 for congenital entero-neuropathy; SQ-104 for osteonecrosis of the femoral head; modified thymidine kinase for glioblastoma; and Gene X for spinal cord injury. The company was formerly known as Gene Techno Science Co.,Ltd. and changed its name to Kidswell Bio Corporation in July 2021. The company was incorporated in 2001 and is headquartered in Chuo, Japan.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 4584.TSE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026
